GLYXAMBI is used to lower blood sugar levels in patients with type 2 diabetes mellitus. GLYXAMBI may be used when diet plus exercise do not provide adequate blood sugar level control either alone or with certain other medicines for diabetes such as metformin. Type 2 diabetes mellitus develops if the body does not make enough insulin or if the insulin that your body makes does not work as well as it should. Insulin is a substance which helps to lower the level of sugar in your blood, especially after meals. When the level of sugar builds up in your blood, this can cause damage to the body’s cells and lead to serious problems with your heart, brain, eyes, circulation, nerves or kidneys. GLYXAMBI contains two different active ingredients:
- empagliflozin, which belongs to a group of medicines called SGLT2 (sodium glucose co - transporter 2) inhibitors, and
- linagliptin, which belongs to a group of medicines called DPP - 4 (dipeptidyl peptidase 4) inhibitors.